Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).
Mo A., Poynton M., Kimber C., Csenar M., Dorée C., Prodger C., Stanworth S., McQuilten Z.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of both supportive and disease-modifying drug treatments for anaemia in people with MDS, comparing them to each other, or the standard of care with or without placebo.